Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Vestibular Schwannoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Johns Hopkins Hospital, Baltimore, Maryland, United States
Mayo Clinic, Rochester, Minnesota, United States
Vanderbilt Bill Wilkerson Center, Nashville, Tennessee, United States
University of Texas Southwestern, Dallas, Texas, United States
Study leads
Aaron Tward, MD
Study Director
Eli Lilly and Company